DFA Large Cap International I holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
DFA Large Cap International Portfolio Institutional Class DFALX
- NAV / 1-Day Return 38.26 / +0.53 %
- Total Assets 8.4B
-
Adj. Expense Ratio
0.180%
- Expense Ratio 0.180%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 0
- Status Open
- TTM Yield 2.73%
- Turnover 8%
USD | NAV as of Jun 13, 2026 | 1-Day Return as of Jun 13, 2026, 12:11 AM GMT+0
Morningstar’s Analysis DFALX
Will DFALX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the DFALX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of DFALX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 9.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
ASML Holding NV ADR | 1.24 | 100M | Technology |
Roche Holding Ag Common Stock Chf.001 | 1.21 | 97M | — |
Shell PLC ADR (Representing - Ordinary Shares) | 1.16 | 93M | Energy |
Royal Bank of Canada | 1.08 | 87M | Financial Services |
TotalEnergies SE | 1.02 | 82M | Energy |
Nestle SA | 1.01 | 81M | Consumer Defensive |
Usd | 0.97 | 78M | Cash and Equivalents |
Future on E-mini S&P 500 Futures | 0.92 | 74M | — |
AstraZeneca PLC | 0.87 | 70M | Healthcare |
BHP Group Ltd | 0.72 | 58M | Basic Materials |
United States